Effects of antipsychotic drug administration on antioxidative defense enzymes in male rat kidney. Issue 20 (17th October 2016)

• Record Type: Journal Article
• Authors: Nikolić-Kokić, Aleksandra; Mijušković, Ana; Tatalović, Nikola; Nestorov, Jelena; Miler, Marko; Oreščanin-Dušić, Zorana; Nikolić, Milan; Milošević, Verica; Blagojević, Duško; Spasić, Mihajlo; Miljević, Čedo
• Is Part Of: Journal of toxicology and environmental health. Volume 79:Issue 20(2016)
• Page Start: 905
• Page End: 911
• Publication Date: 2016-10-17
• Subjects: Toxicology -- Periodicals; Environmental health -- Periodicals; 615.90205
• DOI: 10.1080/15287394.2016.1201706
• Languages: English
• ISSNs: 1528-7394

Abstract

ABSTRACT: The use of atypical antipsychotic drugs (APD) was reported to be associated with adverse effects on the kidneys. Thus, the aim of this study was to examine whether APD exerted their adverse effects by interfering with the renal antioxidant defense system. Male 3-mo-old Wistar rats were treated for 28 d with ziprasidone (ZIP), clozapine (CLO), or sertindole (SER) using a daily dose recommended for antipsychotic drug therapy. The expression and activities of antioxidant enzymes superoxide dismutase (SOD) type 1 and type 2, catalase (CAT), glutathione reductase (GR), and glutathione S -transferases (GSTs) activity were measured in the kidneys. Changes in the kidneys were also evaluated histologically. Ziprasidone, CLO, and SER reduced renal SOD type 1 and type 2 activities. Decreased CAT activity was observed only in SER-treated rats. An inhibition in GR activity and increased activity of GST was found only after treatment with CLO. Histological analysis showed dilatation of proximal tubules in kidneys with all three drugs. In conclusion, data indicate that redox disturbances may contribute to renal morphologic alterations in proximal tubules in rats treated with all APD.